Newborn anaesthesia: pharmacological considerations.
D000375:Aging; D000758:Anesthesia; D000769:Anesthesia, Inhalation / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D005283:Fentanyl / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000378:metabolism; D006221:Halothane / Q000009:adverse effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007530:Isoflurane / Q000009:adverse effects; D007649:Ketamine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D007700:Kinetics; D009467:Neuromuscular Depolarizing Agents / Q000008:administration & dosage / Q000009:adverse effects; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage / Q000009:adverse effects; D013390:Succinylcholine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism
D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D007649:Ketamine; D007530:Isoflurane; D013390:Succinylcholine; D005283:Fentanyl; D006221:Halothane